- Home
- IKT vs AMLI Comparison
IKT vs AMLI Comparison
Compare IKT & AMLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- AMLI
- Stock Information
- Founded
- IKT 2008
- AMLI 1974
- Country
- IKT United States
- AMLI Canada
- Employees
- IKT N/A
- AMLI N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- AMLI Industrial Machinery/Components
- Sector
- IKT Health Care
- AMLI Industrials
- Exchange
- IKT Nasdaq
- AMLI Nasdaq
- Market Cap
- IKT 159.2M
- AMLI 154.6M
- IPO Year
- IKT 2020
- AMLI N/A
- Fundamental
- Price
- IKT $2.31
- AMLI $0.71
- Analyst Decision
- IKT Strong Buy
- AMLI Strong Buy
- Analyst Count
- IKT 2
- AMLI 1
- Target Price
- IKT $6.50
- AMLI $3.25
- AVG Volume (30 Days)
- IKT 310.9K
- AMLI 429.7K
- Earning Date
- IKT 11-14-2024
- AMLI 01-14-2025
- Dividend Yield
- IKT N/A
- AMLI N/A
- EPS Growth
- IKT N/A
- AMLI N/A
- EPS
- IKT N/A
- AMLI N/A
- Revenue
- IKT $1.00
- AMLI N/A
- Revenue This Year
- IKT N/A
- AMLI N/A
- Revenue Next Year
- IKT N/A
- AMLI N/A
- P/E Ratio
- IKT N/A
- AMLI N/A
- Revenue Growth
- IKT N/A
- AMLI N/A
- 52 Week Low
- IKT $0.85
- AMLI $0.32
- 52 Week High
- IKT $3.82
- AMLI $1.29
- Technical
- Relative Strength Index (RSI)
- IKT 52.09
- AMLI 49.18
- Support Level
- IKT $1.75
- AMLI $0.68
- Resistance Level
- IKT $2.10
- AMLI $0.77
- Average True Range (ATR)
- IKT 0.33
- AMLI 0.06
- MACD
- IKT -0.10
- AMLI -0.01
- Stochastic Oscillator
- IKT 28.87
- AMLI 54.84
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About AMLI American Lithium Corp.
American Lithium Corp is an exploration-stage company. It is engaged in the identification, acquisition, and exploration of mineral interests in the United States of America and Peru. Its projects include TLC Lithium, Falchani Lithium, and Macusani Uranium project.